XML 63 R47.htm IDEA: XBRL DOCUMENT v3.23.3
Summary of Significant Accounting Policies - Schedule of Intangible Assets (Detail)
3 Months Ended
Jul. 01, 2023
USD ($)
Sep. 24, 2022
USD ($)
Jun. 25, 2022
USD ($)
Sep. 30, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 25, 2021
USD ($)
Finite-Lived Intangible Assets [Line Items]            
Gross Carrying Value   $ 5,518,200,000   $ 5,342,000,000    
Accumulated Amortization   4,237,600,000   4,453,400,000    
Impairment charge $ 186,900,000          
In Process Research and Development [Member]            
Finite-Lived Intangible Assets [Line Items]            
Impairment charge 10,500,000          
ultrasound imaging assets, equipment            
Finite-Lived Intangible Assets [Line Items]            
Impairment charge $ 5,800,000          
Developed technology            
Finite-Lived Intangible Assets [Line Items]            
Gross Carrying Value   4,565,600,000   4,411,000,000    
Accumulated Amortization   3,458,200,000   3,649,500,000    
In Process Research and Development [Member]            
Finite-Lived Intangible Assets [Line Items]            
Gross Carrying Value   33,000,000.0   25,700,000    
Accumulated Amortization   0   0    
Indefinite-Lived Intangible Assets (Excluding Goodwill), Fair Value Disclosure       26,500,000    
In Process Research and Development [Member] | Valuation Technique, Discounted Cash Flow            
Finite-Lived Intangible Assets [Line Items]            
Intangible Asset, Measurement Input 0.170          
Customer relationships            
Finite-Lived Intangible Assets [Line Items]            
Gross Carrying Value   601,900,000   600,000,000.0    
Accumulated Amortization   535,600,000   550,600,000    
Trade Names [Member]            
Finite-Lived Intangible Assets [Line Items]            
Gross Carrying Value   265,200,000   253,600,000    
Accumulated Amortization   203,300,000   212,800,000    
Acquired intangible assets [Member]            
Finite-Lived Intangible Assets [Line Items]            
Gross Carrying Value   5,465,700,000   5,290,300,000    
Accumulated Amortization   4,197,100,000   4,412,900,000    
Internal-use software [Member]            
Finite-Lived Intangible Assets [Line Items]            
Gross Carrying Value   26,000,000.0   24,000,000.0    
Accumulated Amortization   19,900,000   17,800,000    
Capitalized software [Member]            
Finite-Lived Intangible Assets [Line Items]            
Gross Carrying Value   26,500,000   27,700,000    
Accumulated Amortization   20,600,000   $ 22,700,000    
ultrasound imaging assets, developed technology            
Finite-Lived Intangible Assets [Line Items]            
Impairment charge $ 20,600,000          
Mobidiag Oy            
Finite-Lived Intangible Assets [Line Items]            
Impairment charge 186,900,000          
Mobidiag Oy | Trade Names [Member]            
Finite-Lived Intangible Assets [Line Items]            
Impairment charge 10,700,000          
Mobidiag Oy | Customer Relationships            
Finite-Lived Intangible Assets [Line Items]            
Impairment charge 10,400,000          
Mobidiag Oy | Developed Technology            
Finite-Lived Intangible Assets [Line Items]            
Impairment charge $ 153,700,000 27,700,000        
Faxitron | Developed Technology            
Finite-Lived Intangible Assets [Line Items]            
Impairment charge     $ 9,200,000      
Bolder Surgical | Trade Names [Member]            
Finite-Lived Intangible Assets [Line Items]            
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill         $ 1,400,000  
Bolder Surgical | Customer Relationships            
Finite-Lived Intangible Assets [Line Items]            
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill           $ 21,700,000
Bolder Surgical | Developed Technology            
Finite-Lived Intangible Assets [Line Items]            
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill           $ 73,600,000
Focal Therapeutics | Developed Technology            
Finite-Lived Intangible Assets [Line Items]            
Impairment charge   $ 8,200,000